TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

FDA Approval Summary: Dabrafenib in Combination with Trametinib for BRAFV600E Mutation-Positive Low-Grade Glioma.

Michael I Barbato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.